Ahead of an expected announcement from the Trump administration that Tylenol use in pregnancy is linked to an increased risk of autism in children, the drugmaker and medical experts are pushing back on the claims.

According to a report from the Washington Post , officials on Monday plan to tie autism to acetaminophen, the active ingredient in Tylenol, while also promoting a lesser-known drug called leucovorin, which is used as a treatment for some symptoms in children with autism. The Wall Street Journal previously reported the announcement was in the works, which the Department of Health and Human Services called "speculation" at the time .

On Sunday, Mr. Trump seemingly confirmed the plans, telling reporters "we're going to do it tomorrow" when asked about the reports.

"I

See Full Page